Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A unique BRCA1 mutation identified in Mongolia.

L Elit1, E Jack, E Kwan

  • 1Department of Obstetrics and Gynecology, McMaster University, Canada. laurie.elit@hrcc.on.ca

International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|July 5, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Beta-Decay Half-Lives beyond ^{54}Ca: A Systematic Survey of Decay Properties Approaching the Neutron Dripline.

Physical review letters·2026
Same author

Understanding Why People Experiencing a Mental Health Crisis Leave the Emergency Department Before Care: A Qualitative Interpretive Study.

International journal of mental health nursing·2024
Same author

Observation of New Isotopes in the Fragmentation of ^{198}Pt at FRIB.

Physical review letters·2024
Same author

The utility of the brief ECT cognitive screen (BECS) for early prediction of cognitive adverse effects from ECT: A CARE network study.

Journal of psychiatric research·2021
Same author

New ^{59}Fe Stellar Decay Rate with Implications for the ^{60}Fe Radioactivity in Massive Stars.

Physical review letters·2021
Same author

A pan-Canadian prospective study of young women with breast cancer: the rationale and protocol design for the RUBY study.

Current oncology (Toronto, Ont.)·2020
Same journal

Corrigendum to "Joint GOG-Foundation (GOG) and European Network of Gynaecological Oncological Trial Groups (ENGOT) clinical trials guidance for operations with industry partners" [International Journal of Gynecological Cancer 36 (2026) 104753].

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society·2026
Same journal

piR-hsa-8111406 promotes proliferation and serves as a novel biomarker for early detection of ovarian cancer: a multi-center retrospective study.

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society·2026
Same journal

Poly(adenosine diphosphate-ribose) polymerase inhibitor maintenance therapy with niraparib in patients with primary advanced or recurrent endometrial cancer receiving dostarlimab plus chemotherapy.

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society·2026
Same journal

Balancing fertility potential and oncologic and obstetric risks: a vignette study on decision-making in fertility-sparing surgery for early-stage cervical cancer.

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society·2026
Same journal

Updated pocket guide for integrated risk stratification in endometrial carcinoma: a practical tool based on European Society of Gynecological Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology 2025 guidelines.

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society·2026
Same journal

How long is enough? Immunotherapy duration in mismatch repair deficient endometrial cancer.

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society·2026
See all related articles

Genetic testing revealed a unique BRCA1 gene mutation in a third-world family with early-onset ovarian cancer. This discovery aids genetic counseling and highlights the need for accessible screening and preventative strategies like prophylactic surgery.

Area of Science:

  • Oncology
  • Genetics
  • Public Health

Background:

  • Early-onset ovarian cancer presents a significant health challenge, particularly in resource-limited settings.
  • Genetic predisposition plays a crucial role in hereditary cancers, necessitating advanced diagnostic approaches.
  • Limited access to genetic testing in third-world countries hinders early detection and intervention for high-risk families.

Observation:

  • A case report details a family in a third-world country with two sisters diagnosed with early-onset ovarian cancer.
  • Genetic assessment identified a novel mutation, 3452delA, on exon 11 of the BRCA1 gene.
  • Testing revealed that 50% of tested family members carried this unique BRCA1 mutation.

Findings:

  • Protein truncation testing and DNA sequencing confirmed the specific BRCA1 mutation (3452delA).

Related Experiment Videos

  • The mutation was present in siblings and offspring, indicating hereditary transmission.
  • This unique mutation may be specific to geographically isolated populations.

    • Implications:

    • Accessible genetic testing is crucial for identifying high-risk individuals in underserved regions.
    • Understanding unique mutations in BRCA1 can inform targeted genetic counseling and preventative strategies.
    • Prophylactic surgery remains a primary management option for hereditary ovarian cancer in resource-limited settings.